Clinical PET in oncology

Clinical Positron Imaging (Netherlands)

Volumn 1, Issue 1, 1998, Pages 15-30

  Coleman, R Edward ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Colorectal cancer; F 18 fluorodeoxyglucose; Head and neck cancer; Lung cancer; Lymphoma; Melanoma; Oncology; Positron emission tomography; Solitary pulmonary nodule; Staging

Indexed keywords

EID: 0001939886     PISSN: 10950397     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1095-0397(97)00004-6     Document Type: Review

References (63)

1. G. Di Chiro Positron emission tomography using F[18F]-fluorodeoxyglucose in brain tumors a powerful diagnostic and prognostic tool Invest. Radiol. 2 1986 360 371
2. G. Di Chiro R.L. DeLaPaz R.A. Brooks Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography Neurology 32 1982 1323 1329
3. O. Warburg The metabolism of tumors 1930 Constable London
4. B.M. Gallagher J.S. Fowler N.I. Gutterson R.R. MacGregor C.N. Wan A.P. Wolf Metabolic trapping as a principle of radiopharmaceutical design some factors responsible for the biodistribution of [18F] 2-deoxy-2-fluoro-D-glucose J. Nucl. Med. 19 1978 1154 1161
5. V.J. Lowe D.M. DeLong J.M. Hoffman R.E. Coleman Optimum scanning protocol for FDG-PET evaluation of pulmonary malignancy J. Nucl. Med. 36 1995 883 887
6. R. Kubota S. Yamada K. Kubota Intratumoral distribution of fluorine-18Fluorodeoxyglucose in vivo high accumulation in macrophages and granulation tissues studied J. Nucl. Med. 33 1992 1972 1977
7. P. Lindholm H. Minn S. Leskinen-Kallion Influence of the blood glucose concentration on FDG uptake in cancer-a PET study J. Nucl. Med. 34 1993 1 6
8. S.F. Barrington M.N. Maisey Skeletal muscle uptake of 18FDG the effect of oral diazepam in tense patients J. Nucl. Med. 37 1996 1127 1129
9. R.J. Hagge T.G. Turkington S.M. Hamblen E.A. Bahtiarian S. Borges-Neto M.W. Hanson Comparison of subjective image quality of 2D vs 3D acquisition in clinical brain PET J. Nucl. Med. 37 1996 77P
10. T.R. DeGrado T.G. Turkington J.J. Williams C.W. Stearns J.M. Hoffman R.E. Coleman Performance characteristics of a whole-body PET scanner J. Nucl. Med. 35 1994 1398 1406
11. C.K. Hoh R.A. Hawkins J.A. Glaspy Cancer detection with whole-body PET using 2-[18F]fluoro-2-deoxy-D-glucose J. Comput. Assist. Tomogr. 17 1993 582 589
12. A. Chatziioannou M. Dahlbom C.K. Hoh Whole-body PET attenuation correction with transmission image segmentation J. Nucl. Med. 37 1996 8P
13. V.J. Lowe F.G. Duhaylongsod E.F. Patz D.M. Delong J.M. Hoffman W.G. Wolfe Pulmonary abnormalities and PET data analysis A retrospective study Radiology 202 1997 435 439
14. K.R. Zasadny R.L. Wahl Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose variations with body weight and a method for correction Radiology 189 1993 847 850
15. M. Dahlbom E.J. Hoffman C.K. Hoh Whole-body positron emission tomography part I. Methods and performance characteristics J. Nucl. Med. 33 1992 1191
16. H. Engel H. Steinert A. Buck Whole-body PET physiologic and artifactual fluorodeoxyglucose accumulations J. Nucl. Med. 37 1996 441 446
17. T.G. Turkington R.J. Jaszczak C.A. Pelizarri C.C. Harris J.R. MacFall J.M. Hoffman Accuracy of registration of PET, SPECT, and MR images of a brain phantom J. Nucl. Med. 34 1993 1587 1594
18. R.E. Coleman J.M. Hoffman M.W. Hanson H.D. Sostman S.C. Schold Clinical application of PET for the evaluation of brain tumors J. Nucl. Med. 32 1991 616 622
19. E.A. Bahtiarian T.G. Turkington Coleman Hawk R.E. Impact of image registration on the interpretation of MRI and FDG PET images in patients with known or suspected brain tumors J. Nucl. Med. 37 1996 22P
20. R.L. Wahl L.E. Quint R.D. Cieslak “Anatometabolic” tumor imaging fusing of FDG PET with CT or MRI to localize foci of increased activity J. Nucl. Med. 34 1993 1190 1196
21. J.B. Alavi A. Alavi J. Chawluk Positron emission tomography in patients with glioma. A predictor of prognosis Cancer 62 1988 1074 1078
22. T. Schifter J.M. Hoffman M.W. Hanson Serial FDG-PET studies in the prediction of survival in patients with primary brain tumors J. Comput. Assist. Tomogr. 17 1993 509 561
23. T.L. Francavilla R.S. Miletich C.G. Di N.J. Patronas H.V. Rizzoli D.C. Wright Positron emission tomography in the detection of malignant degeneration of low-grade gliomas Neurosurgery 24 1989 1 5
24. M.W. Hanson M.J. Glantz J.M. Hoffman FDG-PET in the selection of brain lesions for biopsy J. Comput. Assist. Tomogr. 15 1991 796 801
25. M.J. Glantz J.M. Hoffman R.E. Coleman Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography Ann. Neurol. 29 1991 347 355
26. G.D. Dooms S. Hecht M. Brant-Zawadski Brain radiation lesions MR imaging Radiology 158 1986 149 155
27. G. Di Chiro N.J. Patronas E.H. Oldfield PET, CT, and NMR of cerebral necrosis following radiotherapy or intraarterial chemotherapy for cerebral tumors A.J.N.R. 6 1985 473 474
28. G. Di Chiro E. Oldfield D.C. Wright Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors PET and neuropathologic studies A.J.R. 150 1988 189 197
29. T. Ogawa I. Kanno F. Shishido Clinical value of PET with 18F-fluorodeoxyglucose and L-methyl-11C-methionine for diagnosis of recurrent brain tumor and radiation injury Acta Radiol. 32 1991 197 202
30. E.E. Kim S.K. Chung T.P. Haynie Differentiation of residual or recurrent tumors from post-treatment changes with F-18 FDG PET Radiographics 12 1992 269 279
31. E.J. Patz V.J. Lowe J.M. Hoffman Focal pulmonary abnormalities evaluation with F-18 fluorodeoxyglucose PET scanning Radiology 188 1993 487 490
32. K.B. Nolop C.G. Rhodes L.H. Brudin Glucose utilization in vivo by human pulmonary neoplasms Cancer 60 1987 2682 2689
33. K. Kubota T. Matsuzawa T. Fujiwara Differential diagnosis of lung tumor with positron emission tomography a prospective study J. Nucl. Med. 31 1990 1927 1932
34. N.C. Gupta A.R. Frank N.A. Dewan Solitary pulmonary nodules detection of malignancy with EPT with 2-[18F]-fluro-2-deoxy-D-glucose Radiology 184 1991 441 447
35. Gambhir, S.S.; Shepherd, J.E.; Shah, B.D.; Hart, E.; Hoh, C.K.; Valk, P.E. et al. Decision analysis for the cost-effective management of solitary pulmonary nodules. J. Clin. Oncology (in press).
36. P.E. Van Schil H.R.H. Van E.L. Schoofs The value of mediastinoscopy in preoperative staging of bronchogenic carcinoma Thorac. Cardiovasc. Surg. 97 1989 240 244
37. J.F. Patt G.M. Glazer M.B. Orringer Radiologic evaluation of the subcarinal lymph nodes a comparative study A.J.R. 151 1988 279 282
38. W.R. Webb The role of magnetic resonance imaging in the assessment of patients with lung cancer a comparison with computed tomography Thorac. Imag. 4 1989 65 75
39. R.L. Wahl L.E. Quint R.L. Greenough Staging of mediastinal non-small cell lung cancer with DG PET, CT and fusion images preliminary prospective evaluation Radiology 191 1994 371 379
40. P.E. Valk T.R. Pounds D.M. Hopkins Staging non-small cell lung cancer by whole-body positron emission tomographic mapping Ann. Thorac. Surg. 60 1995 1573 1582
41. J.J. Erasmus E.F. Patz H.P. McAdams J.G. Murray J. Herndon R.E. Coleman Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxy-glucose positron emission tomography A.J.R. 168 1997 1357 1360
42. S.S. Gambhir C.G. Hoh M.E. Phelps I. Madar J. Maddahi Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma J. Nucl. Med. 37 1996 1428 1436
43. Y. Ichiya Y. Kuwabara M. Otsuka Assessment of response to cancer therapy using fluorine-18-fluorode-oxyglucose and positron emission tomography J. Nucl. Med. 32 1991 1655 1660
44. M.E. Hebert V.J. Lowe J.M. Hoffman E.F. Patz M.S. Anscher Positron emission tomography in the pretreatment evaluations and follow-up of non-small cell lung cancer patients treated with radiotherapy preliminary findings Am. J. Clin. Oncol. 19 1996 416 421
45. L.G. Strauss P.S. Conti The applications of PET in clinical oncology J. Nucl. Med. 32 1991 623 648
46. P.S. Conti D.L. Lilien K. Hawley J. Keppler S.T. Grafton J.R. Bading PET and [18F]-FDG in oncology a clinical update Nucl. Med. Biol. 23 1996 717 735
47. D. Delbeke J.V. Vitola M.P. Sandler Staging recurrent metastatic colorectal carcinoma with PET J. Nucl. Med. 38 1997 1196 1201
48. U. Haberkorn L.G. Strauss A. Dimitrakopoulos PET studies of fluorodeoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy J. Nucl. Med. 32 1991 1485 1490
49. R.L. Wahl R.L. Cody G.D. Hutchins E.E. Mudgett Primary and metastatic breast carcinoma initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose Radiology 179 1991 765 770
50. L.P. Adler J.P. Crowe N.K. Al Kaisi J.L. Sunshine Evaluation of breast masses and axillary lymph nodes with [F-18] 2-deoxy-2-fluoro-D-glucose PET Radiology 187 1993 743 750
51. O.E. Nieweg E.E. Kim W.H. Wong Positron emission tomography with fluorine-19-deoxyglucose in the detection and staging of breast cancer Cancer 71 1993 3920 3925
52. N. Avril J. Dose F. Janiche Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-[fluorine-18]-fluoro-2-deoxy-D-glucose J. Natl. Cancer Inst. 88 1996 204 209
53. H.C. Steinert R.A. Huch Boni A. Buck Malignant melanoma staging with whole-body positron emission tomography and 2-[18F]-Fluoro-2-deoxy-D-glucose Radiology 195 1995 705 711
54. C.K. Hoh J. Glaspy P. Rosen Whole-body FDG-PET imaging for staging of Hodgkin’s disease and lymphoma J. Nucl. Med. 38 1997 343 348
55. J.S. Newman I.R. Francis M.S. Kaminski R.L. Wahl Imaging of lymphoma with PET with 2-[18F]-fluoro-2-deoxy-D-glucose correlation with CT Radiology 190 1994 111 116
56. J.W. Bailet E. Abemayor B.A. Jabour R.A. Hawkins C. Ho P.H. Ward Positron emission tomography a new, precise imaging modality for detection of primary head and neck tumors and assessment of cervical adenopathy Laryngoscope 102 1992 281 288
57. B.A. Jabour Y. Choi C.K. Hoh Extracranial head and neck PET imaging with 2-[F-18]fluoro-2-deoxy-D-glucose and MR imaging correlation Radiology 186 1993 27 35
58. U. Haberkorn L.G. Strauss A. Dimitrakopoulou Fluorodeoxyglucose imaging of advanced head and neck cancer after chemotherapy J. Nucl. Med. 34 1993 12 17
59. L. Chaiken S. Rege C. Hoh Positron emission tomography with fluorodeoxyglucose to evaluate tumor response and control after radiation therapy Int. J. Radiat. Oncol. Biol. Phys. 27 1993 455 464
60. D.N. Jones G.B. McCowage H.D. Sostman D.M. Brizel L. Layfield H.C. Charles Monitoring of neoadjuvant therapy response of soft-tissue and musculoskeletal sarcoma using fluorine-18-FDG PET J. Nucl. Med. 37 1996 1434 1444
61. K.F. Hubner T.W. McDonald J.G. Niethammer Assessment of primary and metastatic ovarian cancer by positron emission tomography (Pet) using 2-[18F]deoxyglucose(2-[18F]fdg) Gynecol. Oncol. 51 1993 197
62. J.C. Stollfuss G. Glatting H. Friess 2-(Fluorine018)-Fluoro-2-Deoxy-D-Glucose PET in detection of pancreatic cancer value of quantitative image interpretation Radiology 195 1995 339 345
63. A.E. Bloom L.P. Adler J.M. Shuck Determination of malignancy of thyroid nodules with positron emission tomography Surgery 114 1993 728 735